logo
welcome
Reuters

Reuters

23andMe cuts 40% of its workforce, discontinues all therapy programs

Reuters
Summary
Nutrition label

80% Informative

23andMe said it is reducing about 40% of its workforce and discontinuing further development of all its therapies.

CEO Anne Wojcicki has been trying to take the company private since April .

After Monday 's restructuring plan, company expects annualized cost savings of more than $35 million .

VR Score

89

Informative language

95

Neutral language

55

Article tone

semi-formal

Language

English

Language complexity

64

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links